Spectral Med Inc

Research Spectral Med Inc (EDT) on Bullrun: market cap CAD 387.31M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerEDT
• ExchangeTO
• CountryCanada
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyCAD
• Market capCAD 387.31M
• Financial periodQ4 2025
• RevenueCAD 382.00K
• Net income-CAD 2.84M
• Free cash flow-CAD 2.71M
• Gross margin-144.0%

Valuation Snapshot

latest market cap is CAD 387.31M.

About Spectral Med Inc

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.

Frequently asked questions

What is Spectral Med Inc's market cap?

Spectral Med Inc's market capitalization is CAD 387.31M.

What does Spectral Med Inc do?

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.